These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25188841)

  • 1. The development and evaluation of a subcutaneous infusion delivery system based on osmotic pump control and gas drive.
    Xie X; Yang Y; Yang Y; Li Z; Zhang H; Chi Q; Cai X; Mei X
    Drug Deliv; 2016 Sep; 23(7):2193-2204. PubMed ID: 25188841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation.
    Gong W; Ma R; Mei D; Jing P; Dong X; Li B; Yang Y; Du L; Mei XG; Hu FQ
    Drug Deliv; 2014 Feb; 21(1):1-7. PubMed ID: 24102136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.
    Li S; Wang X; Wang Y; Zhao Q; Zhang L; Yang X; Liu D; Pan W
    Drug Dev Ind Pharm; 2015; 41(12):2089-99. PubMed ID: 26304493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel gastric-resident osmotic pump tablet: in vitro and in vivo evaluation.
    Guan J; Zhou L; Nie S; Yan T; Tang X; Pan W
    Int J Pharm; 2010 Jan; 383(1-2):30-6. PubMed ID: 19733646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel bi-layer ascending release osmotic pump tablet: in vitro investigation and in vivo investigation in pharmacokinetic study and IVIVC evaluation.
    Xu H; Li Z; Pan H; Zhang Z; Liu D; Tian B; Ma S; Song S; Pan W
    Int J Pharm; 2013 Dec; 458(1):181-7. PubMed ID: 24095815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system.
    Gong W; Liu Y; Mei DY; Yang M; Mei XG
    Drug Dev Ind Pharm; 2015 Mar; 41(3):464-9. PubMed ID: 24400982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inlay osmotic pump tablets containing metformin and glipizide.
    Patel RB; Patel GN; Patel HR; Patel MM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1244-52. PubMed ID: 21466414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
    Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe.
    Li XD; Pan WS; Nie SF; Wu LJ
    J Control Release; 2004 May; 96(3):359-67. PubMed ID: 15120893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of a novel floating osmotic pump system.
    Zhang Z; Peng B; Yang X; Wang C; Sun G; Pan W
    J Pharm Pharm Sci; 2009; 12(1):129-37. PubMed ID: 19470297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluations of a novel pulsed and controlled osmotic pump capsule.
    Zhang W; Zhang L; Qu X; Zhu Z; Pan Y; Guan J; Pan W
    Drug Dev Ind Pharm; 2015 Feb; 41(2):322-32. PubMed ID: 24295490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
    Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
    Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs.
    Shokri J; Ahmadi P; Rashidi P; Shahsavari M; Rajabi-Siahboomi A; Nokhodchi A
    Eur J Pharm Biopharm; 2008 Feb; 68(2):289-97. PubMed ID: 17616378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of critical core formulation and process parameters for osmotic pump oral drug delivery.
    Missaghi S; Patel P; Farrell TP; Huatan H; Rajabi-Siahboomi AR
    AAPS PharmSciTech; 2014 Feb; 15(1):149-60. PubMed ID: 24222269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
    Song QL; Li P; Li YM
    Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.
    Li X; Jiang Q; Du L; Wang C; Chi Q
    Pharmazie; 2012 Aug; 67(8):695-700. PubMed ID: 22957434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study and Evaluation on Preparation of Monolithic Osmotic Pump Tablet of Resveratrol].
    Wu XC; Hao HJ; Song XY; Zhang YZ; Liu YX; Zhang HQ
    Zhong Yao Cai; 2015 Aug; 38(8):1732-5. PubMed ID: 26983250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.